Prostate cancer metabolite quantification relative to water in 1H-MRSI in vivo at 3 Tesla

Mary A. McLean, Tristan Barrett, Vincent J. Gnanapragasam, Andrew N. Priest, Ilse Joubert, David J. Lomas, David E. Neal, John R. Griffiths, Evis Sala

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

1H magnetic resonance spectroscopic imaging was performed on 16 men with suspected prostate cancer using an 8-channel external receive coil at 3 T. Choline and citrate (Cit) signals were measured in prostate lesions and normal-appearing peripheral zone as identified on T2-weighted images. Metabolites were quantified relative to unsuppressed water from a separately acquired magnetic resonance spectroscopic imaging dataset using LCModel. Validation experiments were also performed in a phantom containing physiological concentrations of choline, Cit, and creatine. In vitro, fair agreement between measured and true concentrations was observed, with the greatest discrepancy being a 35% underestimation of Cit. In vivo, one dataset was rejected for failure to meet the quality criterion of linewidth <15 Hz, and in 6 of 15 subjects, insufficient normal-appearing peripheral zone tissue was identified for study. Lesions were found to have higher choline and choline/Cit, and lower Cit, than normal-appearing peripheral zone. The smaller skew of data obtained using water normalization in comparison with metabolite ratios suggests potential usefulness in longitudinal tumor monitoring and in studies of treatment effects.

Original languageEnglish
Pages (from-to)914-919
Number of pages6
JournalMagnetic Resonance in Medicine
Volume65
Issue number4
DOIs
StatePublished - Apr 2011
Externally publishedYes

Keywords

  • choline
  • citrate
  • magnetic resonance spectroscopy
  • prostate cancer
  • quantification

Fingerprint

Dive into the research topics of 'Prostate cancer metabolite quantification relative to water in 1H-MRSI in vivo at 3 Tesla'. Together they form a unique fingerprint.

Cite this